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envelope that has been modified by the insertion of two
integral membrane glycoproteins, E (53 kDa) and prM (18-20
kDa). The virion is 45 nm to 50 nm in diameter (Figure 2).
Late in virus maturation, the prM protein is cleaved to M
protein (8 kDa) by a cellular protease, and the M protein is
incorporated into the mature virion. The genome also encodes
seven nonstructural proteins (NS1, NS2a, NS2a, NS3, NS4a,
NS4b, and NS5) that make up the intracellular replication
machinery of the virus. E-glycoprotein, the most immunolog-
ically important structural protein, is the viral hemagglutinin
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Figure 1. Genomic structure of flaviviruses. The flavivirus genome is
11,000 to 12,000 nucleotides long. Both the 5'- and 3'- ends contain
noncoding (NC) regions. The genome encodes 10 proteins, 3 of which
are structural proteins (C, M, and E), and 7 of which are
nonstructural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, and
NS5). The M protein is synthesized as a precursor (prM) protein. The
prM protein is processed to pr + M protein late in the virus
maturation by a convertase enzyme (furin).
The recognition of West Nile (WN) virus in the Western
Hemisphere in the summer of 1999 marked the first
introduction in recent history of an Old World flavivirus into
the New World (1,2). The United States is not alone, however,
in reporting new or heightened activity in humans and other
animals, and incursions of flaviviruses into new areas are
likely to continue through increasing global commerce and
travel. Similar expansion of other flaviviruses has been
documented. Dengue viruses, perhaps the most important
human flaviviral pathogens, have spread from roots in Asia to
all tropical regions (3-5). Japanese encephalitis (JE) virus has
recently encroached on the northern shores of Australia and
may soon become endemic in that continent (6-9). This issue of
Emerging Infectious Diseases focuses on current understand-
ing of the biology, ecology, and epidemiology of WN virus.
WN virus, a member of the family Flaviviridae (genus
Flavivirus) (10), was first isolated in 1937 in the West Nile
district of Uganda (11). Flaviviruses have a 30- to 35-nm
icosahedral core composed of multiple copies of a 12-kDa
capsid protein. The capsid encloses a single-stranded,
positive-sense RNA of approximately 12,000 nucleotides
(Figure 1). The capsid is enclosed in a host cell-derived Figure 2. Diagram of the flavivirus virion. An icosahedral
nucleocapsid (half shown here) encloses the virion RNA. The virion
has an envelope derived from the host cell membranes. E-
glycoprotein (E), an integral membrane protein, is arranged as
homodimers (head-to-tail) and associates with the other integral
membrane proteins prM protein (in immature virions).612 Emerging Infectious Diseases Vol. 7, No. 4, July–August 2001
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and also mediates virus-host cell binding. It elicits most of the
virus neutralizing antibodies. WN virus is a member of the JE
virus serocomplex (Table) (12), which contains a number of
viruses also associated with human encephalitis: JE, St.
Louis encephalitis (SLE), Murray Valley encephalitis, and
Kunjin (a subtype of WN). All flaviviruses are closely related
antigenically, which accounts for the serologic cross-reactions
observed in the diagnostic laboratory. Members of the JE
complex are even more closely related, often needing
specialized tests (e.g., virus neutralization assays) to
differentiate the infecting flavivirus (13). Because of the close
antigenic relationships between the flaviviruses, acute- and
convalescent-phase serum specimens from patients are
required to fully assess antibody response. A useful
outgrowth of the recent WN virus activity has been the
development, standardization, and implementation of rapid
techniques for antibody and virus detection (14-16). These
rapid, sensitive techniques permitted identification of
overwintering mosquitoes in New York City in 2000 and two
human WN encephalitis cases in Israel in 1999 (17,18).
Since the original isolation of WN virus, outbreaks have
occurred infrequently in humans, those in Israel (1951-1954
and 1957) and South Africa (1974) being most notable. Since
the mid-1990s, however, three disturbing epidemiologic
trends for WN virus have emerged: 1) increase in frequency of
outbreaks in humans and horses (Romania 1996; Morocco
1996; Tunisia 1997; Italy 1998; Russia, the United States,
and Israel 1999; and Israel, France, and the United States
2000)(19-23); 2) apparent increase in severe human disease
(2,19,20,22,24,25) (confirmed human infections in recent
outbreaks: Romania, 393 cases; Russia [Volgograd], 942
cases; United States, 62 cases in 1999 and 21 in 2000; Israel,
2 cases in 1999 and 417 in 2000); and 3) high avian death rates
accompanying the human outbreaks, in outbreaks in Israel
and the United States.
Recent outbreaks of WN virus have been accompanied by
an apparent evolution of a new WN virus variant. WN virus
can be divided genetically into two lineages (26-29). Only
members of lineage 1 WN viruses have been associated with
clinical human encephalitis (the lineage of the WN virus
causing the human outbreak in South Africa in 1974 is under
contention). Lineage 1 WN viruses have been isolated from
Africa, India, Europe, Asia, and North America. In addition,
Kunjin virus, an apparent subtype of lineage 1 WN viruses,
cocirculates in Australia with a second encephalitis virus
member of the JE virus complex, Murray Valley encephalitis
virus (26). Lineage 2 WN viruses are maintained in enzootic
foci in Africa and have not been associated with clinical
human encephalitis. Among lineage 1 WN viruses, the
viruses causing the recent human and equine outbreaks
throughout Europe and Asia have been most closely related to
a WN virus first isolated in Romania in 1996 (ROM96) and
subsequently in Kenya in 1998 (25,30,31). The WN virus
responsible for the U.S. outbreak (NY99) is genetically
distinguishable from the ROM96-like viruses. The closest
relative of NY99 virus was a virus circulating in Israel from
1997 to 2000 (Isr98). Only the United States and Israel have
reported illness and death in humans and animals caused by
this Isr98/NY99 variant of WN virus (18,28). The reason for
this is not known. The genotype of NY99 WN virus in the
United States has remained stable. Very few genomic changes
occurred in the NY99 WN virus between the 1999 and 2000
WN virus outbreaks (32; Lanciotti, pers. comm.).
The 2000 WN virus outbreak in humans and birds in
Israel was caused by cocirculation of both the ROM96 and the
Isr98 variants of WN virus (33; C. Banet, manuscript in
preparation). Although these are the first reports of two
genetic variants of WN virus causing a single WN
encephalitis outbreak in humans and birds, similar mixed
human flavivirus outbreaks have been documented for
dengue virus (34).
The close genetic relationship between WN virus isolates
from Israel and New York suggests that the virus was
imported into North America from the Middle East. The
means of its introduction (infected bird, mosquito, human, or
another vertebrate host) will likely remain unknown. A
striking feature of the initial human epidemic in New York
City in 1999 was the high number of avian deaths in the
accompanying epizootic, particularly in American Crows
(Corvus brachrhynchos) and other corvids (35,36). Subse-
quent work demonstrating near 100% death rates among
experimentally infected American Crows with NY99 WN
virus has confirmed this observation (R. McLean, pers.
comm.). Although one early study showed high death rates
among Egyptian Hooded Crows (Corvus corone) and House
Sparrows (Passer domesticus) experimentally infected with
the prototype Egypt 101 WN virus strain (37), the epizootic in
Israel in 1997 to 2000 was the first in the Old World
demonstrating high avian death rates (38). Whether high
avian death rates in the United States are due to higher
virulence of the circulating strains or to higher susceptibility
in North American birds requires further evaluation.
High avian death rates during the 1999 epizootic in the
New York City area prompted an avian mortality surveillance
system to track the spread of WN virus in the eastern and
southern United States. Surveillance showed expansion of
viral activity to 12 states in 2000, extending from the
Canadian border to North Carolina, a distance of 900 km (39).
Pronounced northward spread of the virus from New York
City was noted in the late spring and early summer and
southward spread in the late summer and fall—a pattern
consistent with bird migration. Through 2000, avian
mortality rate surveillance has documented WN virus
infection in 76 North American native and captive bird
species. Although American Crows were by far the most
commonly identified species, this may reflect the lethality of
infection in this species, rather than its importance as a
reservoir host.
Table. Distribution of Japanese encephalitis (JE) virus serocomplex viruses
Virus Abbreviation Geographic location
Cacipacore CPC South America
Koutango KOU Africa
Japanese encephalitis JE Asia, Oceania,
  Australiaa
Murray Valley encephalitis MVE Australia
Alfuy ALF Australia
St. Louis encephalitis SLE North America,
  South America
West Nile encephalitis WN Africa, Asia, Europe,
  North America
Kunjin KUN Australia
Yaounde YAO Africa
aJE virus has occasionally been introduced into Australia. Classification from (12).613 Vol. 7, No. 4, July–August 2001 Emerging Infectious Diseases
West Nile Virus
Despite the substantial geographic expansion of WN
virus activity documented by avian mortality surveillance in
2000, human infections were noted only in New York City and
surrounding counties in New Jersey and Connecticut (39).
Ten of the 21 infected persons identified in 2000 lived on
Staten Island, the only part of New York City without
documented WN virus infections in humans in 1999. The
reason that the 2000 human epidemic remained focal despite
a widely geographically expanding epizootic is unknown.
Extensive spring and early summer larval mosquito control
efforts in urban areas of the Northeast likely contributed to
decreased human exposure to mosquitoes.
In addition to high mortality rates of 5% to 14% among
persons with neurologic symptoms in the recent U.S., Romanian,
Russian, and Israeli outbreaks, other clinical aspects (e.g.,
profound motor weakness and infrequency of skin rash and
lymphadenopathy) differ from those of earlier outbreaks
(19,20,22,25,39,40). Serologic surveys accompanying the
Romanian (1996) and two U.S. outbreaks (1999 and 2000)
indicated that severe neurologic illness developed in <1% of
persons infected with WN virus, with systemic febrile illness
developing in approximately 20% of those infected (40,41).
In the United States in both 1999 and 2000, infections in
humans peaked in August and in horses in September (39,42),
suggesting either different mosquito species transmitting the
virus to humans and horses or temporal differences in
exposure to the same species. In 2000, 14 mosquito species in
five states had evidence of WN virus infection (by culture or
nucleic acid amplification) (39). Since mosquitoes of the genus
Culex are the principal maintenance vectors in the Old World,
not surprisingly, Cx. pipiens and Cx. restuans—common,
ornithophilic maintenance vectors for SLE in the northeast-
ern United States (43)—were by far the most frequently
identified species with WN virus in 2000 (39). However, which
species are most important for transmission to humans or
horses remains unknown. Extensive mosquito collections
from Connecticut and New York State indicated that
Cx. pipiens was present in high numbers and had high WN
virus infection rates in early August, coinciding with a
subsequent peak in human disease in the New York City area
(44,45). One important observation was the high WN virus
infection rates in and abundance of Cx. salinarius mosquitoes
on Staten Island in 2000, which temporally coincided with the
human outbreak (46). This species indiscriminately feeds on
both birds and mammals and readily bites humans.
Experience with WN virus in the Old World and SLE
virus in the Americas may provide clues to the eventual
outcome of WN virus in the Americas. The broad geographic
distribution of WN virus in Africa, Europe, the Middle East,
and western Asia suggests potential for wide geographic
distribution in the Americas. The principal mosquito vectors
and avian host species for SLE virus vary regionally; the
broad range of mosquito vectors and avian host species for
WN virus in the Old World also suggests that a similar
pattern can occur in the Americas for WN virus (23). Further
study of the ecology and epidemiology of WN virus in areas
where the virus has been endemic for a long time (e.g., the
Nile Delta in Egypt) will provide additional clues about what
can be expected in the Americas.
Outbreaks caused by WN and SLE viruses have been
difficult to predict, in part because of our incomplete
knowledge of the viruses’ complex ecology. Weather data
suggest that hot, dry summers may promote human
outbreaks caused by these two viruses (25,40,47,48). The
mean July temperature in the New York City area in 1999
was among the highest on record, while 2000 was compara-
tively cool. However, climate and weather influence mosquito
populations and arboviral recrudescence in complex ways;
simple generalizations about weather have had poor predic-
tive value for SLE forecasting and will likely be equally un-
predictive for WN virus forecasting in any given area (48,49).
In the United States, first attempts have been made to
predict WN virus human epidemics in a county on the basis of
avian mortality data (50); efforts to interpret avian mortality
or other surveillance data at a more local level for more
focused emergency mosquito control are at an even earlier
stage of development (46,51). To prevent WN virus infection
in humans, extensive early season larval control has been
recommended and undertaken, as have the development and
dissemination of public health messages for reducing
personal exposure to mosquito bites (52). The efficacy and
cost-effectiveness of these prevention measures, along with
application of pesticides to control adult mosquitoes, require
further evaluation. These evaluations are likely to be
hindered by the sporadic nature of human WN epidemics.
Given our incomplete and evolving knowledge of the ecology
and public health impact of WN virus in the Americas, as well
as the efficacy of control efforts, the virus will remain an
important public health challenge in the next decade.
References
  1. Asnis DS, Conetta R, Teixeira AA, Waldman G, Sampson BA.  The
West Nile Virus outbreak of 1999 in New York: the Flushing
Hospital experience. Clin Infect Dis 2000;30:413-8.
  2. Nash D, Mostashari F, Fine A, Miller J, O’Leary D, Murray K, et al.
Outbreak of West Nile virus infection, New York City area, 1999. N
Engl J Med 2001;344:1807-14.
  3. Gubler DJ. Dengue and dengue hemorrhagic fever in the Americas.
P R Health Sci J 1987;6:107-11.
    4. Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: the
emergence of a global health problem. Emerg Infect Dis 1995;1:55-7.
  5. Gubler DJ. The global pandemic of dengue/dengue haemorrhagic
fever: current status and prospects for the future. Ann Acad Med
Singapore 1998;27:227-34.
  6. Ritchie SA, Phillips D, Broom A, Mackenzie J, Poidinger M, van
den Hurk A. Isolation of Japanese encephalitis virus from Culex
annulirostris in Australia. Am J Trop Med Hyg 1997;56:80-4.
    7. Hanna JN, Ritchie SA, Phillips DA, Shield J, Bailey MC,
Mackenzie JS, et al. An outbreak of Japanese encephalitis in the
Torres Strait, Australia, 1995. Med J Aust 1996;165:256-60.
  8. Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den
Hurk AF, et al. Japanese encephalitis in north Queensland,
Australia, 1998. Med J Aust 1999;170:533-6.
  9. Mackenzie JS, Broom AK, Hall RA, Johansen CA, Lindsay MD,
Phillips DA, et al. Arboviruses in the Australian region, 1990 to
1998. Commun Dis Intell 1998;22:93-100.
10. Gubler DJ, Roehrig JT. Togaviridae and Flaviviridae. In: Collier L,
Balows A, Sussman M, editors. Topley and Wilson’s microbiology and
microbial infections. London: Arnold Publishing; 1999. p. 579-600.
11. Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic
virus isolated from the blood of a native of Uganda. Am J Trop Med
1940;20:471-92.
12. Heinz FX, Collett MS, Purcell RH, Gould EA, Howard CR, Houghton
M, et al. Family: Flaviviridae. In: Van Regenmortel MHV, Fauquet
CM, Bishop DHL, Carstens EB, Estes MK, Lemon SM, et al., editors.
Virus taxonomy: classification and nomenclature of viruses. 7th Report
of the International Committee on Taxonomy of Viruses. San Diego:
Academic Press; 1999. p. 859-78.614 Emerging Infectious Diseases Vol. 7, No. 4, July–August 2001
West Nile Virus
13. Roehrig JT. Arboviruses. In: Specter S, Hodinka RL, Young SA,
editors. Clinical virology manual. 3rd ed. Washington: American
Society for Microbiology; 1999. p. 356-73.
14. Johnson DJ, Ostlund EN, Pedersen DD, Schmitt BJ. Detection of
North American West Nile Virus in animal tissue by a reverse
transcription-nested polymerase chain reaction assay. Emerg
Infect Dis 2001;7:739-41.
15. Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, Mitchell CJ, Savage
HM, et al. Rapid detection of West Nile virus from human clinical
specimens, field-collected mosquitoes, and avian samples by a
TaqMan reverse transcriptase-PCR assay. J Clin Microbiol
2000;38:4066-71.
16. Briese T, Glass WG, Lipkin WI. Detection of West Nile virus
sequences in cerebrospinal fluid. Lancet 2000;355:1614-5.
17. Nasci RS, Savage HM, White DF, Miller JR, Cropp BC, Godsey MS,
et al. West Nile virus in overwintering Culex mosquitoes, New York
City, 2000. Emerg Infect Dis 2001;7:742-4.
18. Giladi M, Metzkor-Cotter E, Martin DA, Siegman-Igra Y, Korczyn
AD, Rosso R, et al. West Nile encephalitis in Israel, 1999: The New
York connection. Emerg Infect Dis 2001;7:659-61.
19. Weinberger M, Pitlik SD, Gandacu D, Lang R, Nassar F, Ben David
D, et al. West Nile fever outbreak, Israel, 2000: Epidemiologic
aspects. Emerg Infect Dis 2001;7:686-91.
20. Chowers MY, Lang R, Nassar F, Ben-David D, Giladi M,
Rubinshtein E, et al. Clinical characteristics of the West Nile Fever
outbreak, Israel, 2000. Emerg Infect Dis 2001;7:675-8.
21. Murgue M, Murri S, Zientara S, Durand B, Durand J-P, Zeller H.
West Nile outbreak in horses in southern France, 2000: the return
after 35 years. Emerg Infect Dis 2001;7:692-6.
22. Weiss D, Carr D, Kellachan J, Tan C, Phillips M, Bresnitz E, et al.
Clinical findings of West Nile virus infection in hospitalized
patients, New York and New Jersey, 2000. Emerg Infect Dis
2001;7:654-8.
23. Hubálek Z, Halouzka J. West Nile fever—a reemerging mosquito-
borne viral disease in Europe. Emerg Infect Dis 1999;5:643-50.
24. Cernescu C, Ruta SM, Tardei G, Grancea C, Moldoveanu L,
Spulbar E, et al. A high number of severe neurologic clinical forms
during an epidemic of West Nile virus infection. Rom J Virol
1997;48:13-25.
25. Platonov AE, Shipulin GA, Shipulina OY, Tyutyunnik EN,
Frolochkina TI, Lanciotti RS, et al. Outbreak of West Nile virus
infection, Volgograd Region, Russia, 1999. Emerg Infect Dis
2001;7:128-32.
26. Scherret JH, Poidinger M, Mackenzie JS, Broom AK, Deubel V,
Lipkin I, et al. The relationships between West Nile and Kunjin
viruses. Emerg Infect Dis 2001;7:697-705.
27. Berthet FX, Zeller HG, Drouet MT, Rauzier J, Digoutte JP, Deubel
V. Extensive nucleotide changes and deletions within the envelope
glycoprotein gene of Euro-African West Nile viruses. J Gen Virol
1997;78:2293-7.
28. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K,
et al. Origin of the West Nile virus responsible for an outbreak of
encephalitis in the northeastern United States. Science
1999;286:2333-7.
29. Jia XY, Briese T, Jordan I, Rambaut A, Chi HC, Mackenzie JS, et
al. Genetic analysis of West Nile New York 1999 encephalitis virus.
Lancet 1999;354:1971-2.
30. Savage HM, Ceianu C, Nicolescu G, Karabatsos N, Lanciotti R,
Vladimirescu A, et al. Entomologic and avian investigations of an
epidemic of West Nile fever in Romania in 1996, with serologic and
molecular characterization of a virus isolate from mosquitoes. Am
J Trop Med Hyg 1999;61:600-11.
31. Miller BR, Nasci RS, Godsey MS, Savage HM, Lutwama JJ,
Lanciotti RS, et al. First field evidence for natural vertical
transmission of West Nile virus in Culex  univittatus complex
mosquitoes from Rift Valley province, Kenya. Am J Trop Med Hyg
2000;62:240-6.
32. Ebel GD, Dupuis AP II, Ngo K, Nicholas D, Kauffman E, Jones SA,
et al. Partial genetic characterization of West Nile virus strains,
New York State, 2000. Emerg Infect Dis 2001;7:650-3.
33. Hindiyeh M, Shulman LM, Mendelson E, Weiss L, Grossman Z,
Bin H. Isolation and characterization of West Nile virus from the
blood of viremic patients during the 2000 outbreak in Israel. Emerg
Infect Dis 2001;7:748-50.
34. Gubler DJ, Kuno G, Sather GE, Waterman SH. A case of natural
concurrent human infection with two dengue viruses. Am J Trop
Med Hyg 1985;34:170-3.
35. Eidson M, Komar N, Sorhage F, Nelson R, Talbot T, Mostashari F,
et al. Crow deaths as a sentinel surveillance system for West Nile
virus in the northeastern United States, 1999. Emerg Infect Dis
2001;7:615-20.
36. Steele KE, Linn MJ, Schoepp RJ, Komar N, Geisbert TW, Manduca
RM, et al. Pathology of fatal West Nile virus infections in native and
exotic birds during the 1999 outbreak in New York City, New York.
Vet Pathol 2000;37:208-24.
37. Work TH, Hurlbut HS, Taylor RM. Indigenous wild birds of the
Nile Delta as potential West Nile virus circulating reservoirs. Am
J Trop Med Hyg 1955;4:872-88.
38. Swayne DE, Beck JR, Smith CS, Shieh W-J, Zaki SR. Fatal
encephalitis and myocarditis in young domestic geese (Anser anser
domesticus) caused by West Nile virus. Emerg Infect Dis
2001;7:751-3.
39. Marfin AA, Petersen LR, Eidson M, Miller J, Hadler J, Farello C, et
al. Widespread West Nile virus activity, eastern United States,
2000. Emerg Infect Dis 2001;7:730-5.
40. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI.  West
Nile encephalitis epidemic in southeastern Romania. Lancet
1998;352:767-71.
41. Centers for Disease Control and Prevention. Serosurveys for West
Nile virus infection—New York and Connecticut Counties, 2000.
MMWR Morb Mortal Wkly Rep 2001;50:31-9.
42. Centers for Disease Control and Prevention. Update: West Nile
virus activity—Eastern United States, 2000. MMWR Morb Mortal
Wkly Rep 2000;49:1044-7.
43. Mitchell CJ, Francy DB, Monath TP. Arthropod vectors. In:
Monath TP, editor. St. Louis encephalitis. Washington: American
Public Health Association; 1999. p. 313-79.
44. Andreadis TG, Anderson JF, Vossbrinck CR. Mosquito
surveillance for West Nile virus in Connecticut, 2000: Isolation
from  Culex pipiens, Cx. restuans, Cx. salinarius, and  Culiseta
melanura. Emerg Infect Dis 2001;7:670-4.
45. White DJ, Kramer LD, Backenson PB, Lukacik G, Johnson G,
Oliver J, et al. Mosquito surveillance and polymerase chain
reaction detection of West Nile virus, New York State. Emerg
Infect Dis 2001;7:643-9.
46. Kulasekera V, Kramer L, Nasci RS, Mostashari F, Cherry B, Trock
SC, et al. West Nile virus infection in mosquitoes, birds, horses, and
humans, Staten Island, New York, 2000. Emerg Infect Dis
2001;7:722-5.
47. Han LL, Popovici F, Alexander JP, Laurentia V, Tengelsen LA,
Cernescu C, et al. Risk factors for West Nile virus infection and
meningoencephalitis, Romania, 1996. J Infect Dis 1999;179:230-3.
48. Reiter P. Weather, vector biology and arboviral recrudescence. In:
Monath TP, editor. The arboviruses: epidemiology and ecology.
Boca Raton: CRC Press; 1999. p. 245-55.
49. Reiter P. Climate change and mosquito-borne disease. Environ
Health Perspect 2001;109:141-61.
50. Eidson M, Miller J, Kramer L, Cherry B, Hagiwara Y, West Nile
Virus Bird Mortality Analysis Group. Dead crow densities and
human cases of West Nile virus, New York State, 2000. Emerg
Infect Dis 2001;7:662-4.
51. Hadler J, Nelson R, McCarthy T, Andreadis T, Lis MJ, French R, et
al. West Nile virus surveillance in Connecticut in 2000: An intense
epizootic without high risk for severe human disease. Emerg Infect
Dis 2001;7:636-42.
52. Centers for Disease Control and Prevention. Epidemic/epizootic
West Nile virus in the United States: revised guidelines for
surveillance, prevention and control. Available at URL: http://
www.cdc.gov/ncidod/dvbid/westnile/publications.htm